Fractional CDM leadership
A named data management lead in your study team, at the fraction of a week the work actually takes. You get senior judgement in the room without a permanent hire.
Preceda provides senior clinical data services — data management, database development and clinical programming — the expertise a study needs, without the headcount.
Most small sponsors don't have a data manager. They have a CRO, a clinical operations lead whose attention is rightly on sites, contracts and study start-up, and a database that hasn't been independently reviewed by anyone who builds them for a living.
The problems surface at UAT, at the first interim, or at database lock — by which point fixing them is more complicated, and costs many times what preventing them would have.
Preceda exists for that gap.
Preceda works across all therapeutic areas and on device studies. Most engagements begin with a call or an email: what you need help with, what you are looking for, and where Preceda can help.
A named data management lead in your study team, at the fraction of a week the work actually takes. You get senior judgement in the room without a permanent hire.
Protocol review, data management plan, CRF design and completion guidelines, database build and validation, edit check specification, UAT, ongoing data review, trial metrics and review listings, reconciliation and database lock — held outside the CRO.
Review of the work being done on your behalf: an assessment of your CRO's data management quality, study build diagnostics, specification review, and the questions your CRO isn't expecting to be asked.
Discrete deliverables at a fixed scope and price, with no ongoing commitment. A protocol review before finalisation. Study metrics and review listings, set up once or produced each month. An independent review of your study build. Often the sensible way to start.
The full scope, so you can find the specific thing you need. Aligned to ICH E6(R3), ICH-GCP and the SCDM Good Clinical Data Management Practices guidance.
Systems are not a constraint. Preceda works in whichever EDC you have chosen — hands-on experience in Medidata Rave and Medrio, and metadata-driven methods that transfer across platforms. Regulatory context spans Swissmedic and HRA-ClinO, EU CTR, FDA and MHRA, and EU MDR with ISO 14155 for device studies.
Anonymised: participant identifiers replaced, study numbers removed. Shown so you can judge the work rather than take my word for it.
By convention, the protocol reaches data management when it is final — to be built from, not commented on. Every problem found after that point costs an amendment.
A protocol review before finalisation asks a different question from the usual feasibility read: not whether the study can be run, but whether it can be collected. Whether the schedule of assessments has a data model. Whether visit windows are defined and reachable. Whether anything is scheduled after end of study.
It is a small piece of work, and the cheapest hour anyone spends on the study.
A written review covering what can be built as written, what is internally inconsistent between the schedule of assessments and the body text, what breaks common study rules, and what will force an amendment once the database exists — with a short list of changes in priority order.
Start with a call or an email. A confidentiality agreement can be in place before any document changes hands.
Sponsors engaging Preceda don't pay for procedures to be written from scratch on their program's timeline. The library already exists, aligned to ICH E6(R3) and SCDM GCDMP, with matching templates for every procedure.
Alongside it: proprietary tooling for Medidata Rave and Medrio study build diagnostics, protocol-to-CRF specification, and metadata-driven data review — built over years of finding the same defects in other people's builds.
The transition from preclinical into the clinic is when a data management plan and CRF specification are needed and nobody internally owns them. Decisions made in those weeks — how endpoints are captured, which checks exist, what the CRO is accountable for — determine how much the rest of the study costs to clean.
It is also the cheapest point at which to fix any of it.
Twenty-nine years in clinical data management, including director-level roles in biotech. The deepest experience is in oncology — early phase and complex designs among them — but the discipline is the same wherever the trial sits, across all therapeutic areas and device studies under MDR.
Oncology is where the data problems tend to be hardest. It is a good place to learn the work, not a limit on where it applies.
Preceda GmbH is a one-person consultancy by design. Engagements are delivered personally: there is no bench, no handover to a junior after the pitch, and no account manager between you and the person doing the work.
BSc Biology, Carnegie Mellon University. Certificate in Leadership and Management, UC Berkeley.
CDISC — CDASH, SDTM, ADaM· ICH-GCP· ICH E6(R3)· SCDM GCDMP· Medidata Rave· Medrio· SAS· Python· Swissmedic / HRA-ClinO· EU CTR· EU MDR / ISO 14155
Working across the Swiss life sciences cluster from Zug, and with sponsors in Germany, the United Kingdom and the United States.
Or not certain your CRO's build will survive contact with real data? I'm glad to have a conversation — nothing to prepare, and I'm more useful once I understand the program.
sarah@preceda.ch